We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.4M
AUM Growth
+$8.29M
Cap. Flow
+$122M
Cap. Flow %
183.83%
Top 10 Hldgs %
32.21%
Holding
297
New
108
Increased
49
Reduced
51
Closed
72

Top Buys

1
INCY icon
Incyte
INCY
+$3.53M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.94M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$2.18M
4
ARAV
Aravive, Inc. Common Stock
ARAV
+$1.54M
5
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.37M

Top Sells

1
GIS icon
General Mills
GIS
+$2.52M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$2.31M
3
AMGN icon
Amgen
AMGN
+$2.08M
4
ABT icon
Abbott
ABT
+$1.72M
5
CLVS
Clovis Oncology, Inc.
CLVS
+$1.56M

Sector Composition

1 Healthcare 41.81%
2 Consumer Discretionary 7.1%
3 Consumer Staples 6.25%
4 Communication Services 0.99%
5 Materials 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
201
PUT
Coca-Cola
KO
$365B
$4K 0.01%
5,800
-11,200
-66% -$509K
RTX icon
202
CALL
RTX Corp
RTX
$262B
$4K 0.01%
+20,816
New +$1.54M
PRTK
203
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$4K 0.01%
+7,800
New +$182K
CASC
204
CALL
DELISTED
Cascadian Therapeutics, Inc.
CASC
$4K 0.01%
+4,000
New +$15.3K
HAIN icon
205
PUT
Hain Celestial
HAIN
$52.5M
$3K ﹤0.01%
3,500
-17,500
-83% -$723K
HOG icon
206
CALL
Harley-Davidson
HOG
$2.82B
$3K ﹤0.01%
10,000
+1,500
+18% +$73K
MDLZ icon
207
CALL
Mondelez International
MDLZ
$78.8B
$3K ﹤0.01%
42,800
-3,700
-8% -$157K
ABT icon
208
PUT
Abbott
ABT
$172B
$2K ﹤0.01%
35,000
– –
BABA icon
209
PUT
Alibaba
BABA
$282B
$2K ﹤0.01%
10,000
– –
ESPR
210
PUT
DELISTED
Esperion Therapeutics
ESPR
$2K ﹤0.01%
7,800
-55,200
-88% -$2.66M
PLCE icon
211
PUT
Children's Place
PLCE
$66M
$2K ﹤0.01%
+11,600
New +$1.25M
OTIC
212
CALL
DELISTED
Otonomy, Inc.
OTIC
$2K ﹤0.01%
67,300
+33,800
+101% +$456K
CA
213
CALL
DELISTED
CA, Inc.
CA
$2K ﹤0.01%
10,000
– –
CCEP icon
214
PUT
Coca-Cola Europacific Partners
CCEP
$46.9B
$1K ﹤0.01%
1,900
– –
CHD icon
215
CALL
Church & Dwight Co
CHD
$23.5B
$1K ﹤0.01%
+16,500
New +$838K
FL
216
CALL
DELISTED
Foot Locker
FL
$1K ﹤0.01%
+7,500
New +$315K
FL
217
PUT
DELISTED
Foot Locker
FL
$1K ﹤0.01%
+5,000
New +$210K
INSM icon
218
PUT
Insmed
INSM
$23.3B
$1K ﹤0.01%
145,500
+37,900
+35% +$722K
BIG
219
PUT
DELISTED
Big Lots, Inc.
BIG
$1K ﹤0.01%
+5,000
New +$246K
RAD
220
CALL
DELISTED
Rite Aid Corporation
RAD
$1K ﹤0.01%
1,525
– –
COL
221
PUT
DELISTED
Rockwell Collins
COL
$1K ﹤0.01%
+961
New +$117K
GGP
222
CALL
DELISTED
GGP Inc.
GGP
$1K ﹤0.01%
+10,000
New +$219K
ZGNX
223
PUT
DELISTED
Zogenix, Inc.
ZGNX
$1K ﹤0.01%
+58,600
New +$795K
A icon
224
CALL
Agilent Technologies
A
$38.4B
– –
-15,500
Closed -$1K
A icon
225
Agilent Technologies
A
$38.4B
– –
-3,236
Closed -$192K
7 8
9
10 11

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2017 Portfolio in Review

As of Q3 2017, FT Options held 297 positions worth $66.4M, up 14% from $58.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FT Options deployed $122M of net new capital in Q3 2017, opening 108 new positions and adding to 49 existing holdings. Its largest new stake was Incyte: 27,887 shares worth $3.26M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was General Mills, an estimated $2.52M trimmed.

  • FT Options's largest Q3 2017 buy was Incyte: 27,887 shares worth $3.26M.
  • FT Options added most to Sio Gene Therapies Inc. Common Stock in Q3 2017, an estimated $1.37M increase.
  • FT Options's biggest Q3 2017 reduction was General Mills, cutting an estimated $2.52M.
  • FT Options fully exited Portola Pharmaceuticals, Inc. in Q3 2017, selling an estimated $2.31M.
  • FT Options's ten largest holdings make up 32% of its $66.4M portfolio in Q3 2017.
  • FT Options opened 108 new positions and closed 72 in Q3 2017.
  • FT Options's portfolio value rose 14% quarter-over-quarter to $66.4M.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.